Immune Privilege Furnishes a Niche for Latent Infection.
CNS
barrier
intraocular inflammation
latency
microbe
retina
tolerance
uveitis
Journal
Frontiers in ophthalmology
ISSN: 2674-0826
Titre abrégé: Front Ophthalmol (Lausanne)
Pays: Switzerland
ID NLM: 9918419176106676
Informations de publication
Date de publication:
2022
2022
Historique:
received:
03
02
2022
accepted:
15
02
2022
medline:
8
3
2022
pubmed:
8
3
2022
entrez:
10
7
2024
Statut:
epublish
Résumé
The microenvironment of the CNS (eye and brain) is fertile ground for infection if the barriers are breached. The result of pathogen invasion is often devastating destruction of tissues. In the eye, inflammation is broadly classified either as "infectious" (i.e. caused by infection) or "non-infectious". However, increasingly, forms of intraocular inflammation (IOI), which clinically appear to be "non-infectious" turn out to be initiated by infectious agents, suggesting that pathogens have been retained in latent or persistent form within ocular tissues and have reactivated to cause overt disease. A similar pathogenesis applies to latent infections in the brain. Not all CNS tissues provide an equally protective niche while different pathogens escape detection using different strategies. This review summarises how immune privilege (IP) in the CNS may be permissive for latent infection and allow the eye and the brain to act as a reservoir of pathogens which often remain undetected for the lifetime of the host but in states of immune deficiency may be activated to cause sight- and life-threatening inflammation.
Identifiants
pubmed: 38983514
doi: 10.3389/fopht.2022.869046
pmc: PMC11182092
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
869046Informations de copyright
Copyright © 2022 Forrester, Mölzer and Kuffova.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.